Sylvie D. R.
- Country
- Belgium
- Department
- Neurology
Research Overview
- A Phase IIa, Randomized, Open-label, Proof-of-Concept Study to Evaluate Safety, Tolerability and Efficacy of Ir CPI in Patients with Spontaneous Intracerebral Haemorrhage - the BIRCH study
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Evaluation of Edoxaban Versus Nonanticoagulant Therapy in High-Risk Atrial Fibrillation Patients with Prior Intracranial Hemorrhage
Data & Insights
Has run more than one trial at 74 of 343 partner sites.
Specializations
Stroke Prevention and Management
The investigator specializes in treating and preventing ischemic stroke conditions, with particular focus on non-cardioembolic ischemic stroke and transient ischemic attacks. Their research extends to innovative therapeutic approaches for acute stroke management.
- Post-stroke preventive therapy
- Acute stroke intervention
- Anticoagulation strategies
Cerebral Hemorrhage Treatment
Expertise in managing various forms of brain hemorrhage, including spontaneous intracerebral hemorrhage and intracranial hemorrhage. The investigator studies innovative therapeutic approaches for patients with bleeding complications.
- Hemorrhage management protocols
- Blood-brain barrier studies
- Neurological recovery assessment
Vascular Medicine
Focus on cerebrovascular disorders and reperfusion therapy, particularly in cases of incomplete vessel reperfusion following mechanical thrombectomy. The investigator explores advanced therapeutic options for complex vascular conditions.
- Vessel occlusion treatment
- Reperfusion strategies
- Thrombolytic therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.